Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1660-1661
Number of pages2
JournalTransplantation
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Transplantation

Cite this